Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Grand Pharmaceutical Group Limited (HK:0512)
HKEX:0512
Grand Pharmaceutical Group Limited (0512) Stock Price & Analysis
1 Followers
0512 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$3.01 - HK$5.04
Previous CloseHK$4.65
Volume1.94M
Average Volume (3M)4.33M
Market Cap
HK$16.51B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)8.7
Beta0.92
Next Earnings
Aug 07, 2024EPS EstimateN/A
Last Dividend Ex-Date
Jun 07, 2024Dividend Yield3.01%
Share Statistics
EPS (TTM)0.53
Shares Outstanding3,549,571,148
10 Day Avg. Volume1,941,800
30 Day Avg. Volume4,330,800
Standard Deviation0.11
R-Squared0.16
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Grand Pharmaceutical Group Limited News
PremiumCompany Announcements
Grand Pharma Announces Board Reshuffle
PremiumCompany Announcements
Grand Pharma Reveals Board and Committee Structure
PremiumCompany Announcements
Grand Pharma’s Innovative Myopia Drug Advances
PremiumCompany Announcements
Grand Pharma Reports Strong Shareholder SupportOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
1.60% Mutual Funds
2.08% Other Institutional Investors
96.31% Public Companies and
Individual Investors
0512 FAQ
What was Grand Pharmaceutical Group Limited’s price range in the past 12 months?
Grand Pharmaceutical Group Limited lowest stock price was HK$3.01 and its highest was HK$5.04 in the past 12 months.
What is Grand Pharmaceutical Group Limited’s market cap?
Currently, no data Available
When is Grand Pharmaceutical Group Limited’s upcoming earnings report date?
Grand Pharmaceutical Group Limited’s upcoming earnings report date is Aug 07, 2024 which is in 37 days.
How were Grand Pharmaceutical Group Limited’s earnings last quarter?
Grand Pharmaceutical Group Limited released its earnings results on Mar 19, 2024. The company reported HK$0.243 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.243.
Is Grand Pharmaceutical Group Limited overvalued?
According to Wall Street analysts Grand Pharmaceutical Group Limited’s price is currently Overvalued.
Does Grand Pharmaceutical Group Limited pay dividends?
Grand Pharmaceutical Group Limited pays a Annually dividend of HK$0.26 which represents an annual dividend yield of 3.01%. See more information on Grand Pharmaceutical Group Limited dividends here
What is Grand Pharmaceutical Group Limited’s EPS estimate?
Grand Pharmaceutical Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Grand Pharmaceutical Group Limited have?
Grand Pharmaceutical Group Limited has 3,549,571,000 shares outstanding.
What happened to Grand Pharmaceutical Group Limited’s price movement after its last earnings report?
Grand Pharmaceutical Group Limited reported an EPS of HK$0.243 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.156%.
Which hedge fund is a major shareholder of Grand Pharmaceutical Group Limited?
Currently, no hedge funds are holding shares in HK:0512
---
Grand Pharmaceutical Group Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
12.48%
12-Months-Change
Fundamentals
Return on Equity
12.83%
Trailing 12-Months
Asset Growth
0.64%
Trailing 12-Months
Company Description
Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Ltd, formerly China Grand Pharmaceutical and Healthcare Holdings Ltd is a drug manufacturer. The company through its subsidiaries manufactures and sells pharmaceutical preparations and medical devices, biotechnology products, nutrition products, specialized pharmaceutical raw materials, and other products. Geographically, it derives a majority of revenue from China and also has a presence in America; Europe; Asia other than the PRC and others.
---
0512 Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---